Expansion of IQVIA and Veeva Partnership Streamlines Clinical Trials Using Advanced Technology

In an exciting development for the life sciences and healthcare sectors, IQVIA and Veeva Systems have announced an expansion of their collaboration, aiming to enhance clinical research capabilities. The partnership now includes the selection of Veeva's Clinical Trial Management System (CTMS), electronic Trial Master File (eTMF), Study Startup, and Site Connect as enterprise standard applications. This initiative is expected to significantly improve the efficiency and speed of clinical trials, while reinforcing a site-centric approach.

Richard Staub, the president of Research and Development Solutions at IQVIA, highlighted how this partnership utilizes the strengths of both companies to create a more integrated workflow for clinical teams. By leveraging the frictionless integration of their technologies, the aim is to facilitate improved decision-making processes and ultimately expedite the delivery of life-changing treatments to patients. This collaboration enhances the capabilities of clinical teams by providing them with a connected way to work, allowing for better communication and efficiency in managing clinical studies.

Previously, IQVIA and Veeva had initiated a partnership focused on Electronic Data Capture (EDC) services, and the current expansion marks a significant step forward in their collaboration. Veeva Systems, known for delivering industry-leading cloud applications for the life sciences sector, adds valuable capabilities to IQVIA's solutions repertoire, which is already recognized for raising industry standards through its healthcare intelligence and commercial insights.

Both companies are steadfast in their commitment to innovation and customer success, serving over 1,500 clients that range from large pharmaceutical companies to emerging biotech firms. The use of Veeva's clinical solutions can now be accessed through IQVIA for sponsors who wish to leverage a comprehensive Veeva technology stack, facilitating the seamless integration of operations within clinical research.

Peter Gassner, the founder and CEO of Veeva Systems, expressed his enthusiasm for the partnership's expansion, emphasizing the continuity of innovation. He stated that this integration will not only benefit clinical research teams but also ultimately enhance patient access to new medical innovations. This focus on improving access to treatments aligns with both companies' missions to support advancements in healthcare outcomes.

To further illuminate these developments, both IQVIA and Veeva invite interested parties to the upcoming Veeva RD and Quality Summit scheduled for October 20-21 in Boston, where industry leaders will discuss the transformative impact of these technologies on clinical research.

About IQVIA

IQVIA, listed on the NYSE as IQV, is a worldwide leader in providing crucial clinical research services and healthcare intelligence tailored to the life sciences sector. The company employs approximately 94,000 professionals in over 100 countries, delivering cutting-edge insights backed by extensive health data and advanced analytics. IQVIA is dedicated to enhancing the development and commercialization of innovative medical treatments with the ultimate aim of improving patient health outcomes globally. The firm is also recognized for its commitment to patient privacy, employing rigorous safeguards that allow for the collection and analysis of health data while protecting individual privacy rights.

About Veeva Systems

Veeva, represented on the NYSE under VEEV, establishes the industry cloud for life sciences, offering a range of applications, consulting, and innovative data solutions. Veeva’s dedication to excellence and customer success has made it a trusted partner to a diverse array of clients within the life science industry. With a focus on innovation, the company is committed to balancing stakeholder interests, including those of customers, employees, and shareholders. For more insights into Veeva’s offerings, visit their official website at veeva.com.

This collaboration between IQVIA and Veeva marks a pivotal moment in the evolving landscape of clinical trials—a landscape that is increasingly defined by the integration of innovative technologies aimed at improving patient care and treatment accessibility.